Alan Colman, Director at VOLITIONRX LTD (VNRX), bought 3,182 shares at $7000.00 ($22.3M) on 2014-09-24, disclosed to the SEC on 2014-09-29.
Open-market purchase of $22.3M VNRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.